chr6-131708917-T-C
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001145659.1(CTAGE9):c.2101A>G(p.Ile701Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000532 in 1,605,820 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145659.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTAGE9 | ENST00000314099.10 | c.2101A>G | p.Ile701Val | missense_variant | Exon 1 of 1 | 6 | NM_001145659.1 | ENSP00000395587.2 | ||
ENPP3 | ENST00000357639.8 | c.1413-9755T>C | intron_variant | Intron 15 of 24 | 1 | NM_005021.5 | ENSP00000350265.3 | |||
ENPP3 | ENST00000414305.5 | c.1413-9755T>C | intron_variant | Intron 16 of 25 | 1 | ENSP00000406261.1 | ||||
ENPP3 | ENST00000358229.6 | c.1413-9755T>C | intron_variant | Intron 15 of 23 | 1 | ENSP00000350964.5 |
Frequencies
GnomAD3 genomes AF: 0.000537 AC: 78AN: 145262Hom.: 1 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000368 AC: 91AN: 247586 AF XY: 0.000364 show subpopulations
GnomAD4 exome AF: 0.000531 AC: 776AN: 1460450Hom.: 9 Cov.: 34 AF XY: 0.000484 AC XY: 352AN XY: 726566 show subpopulations
GnomAD4 genome AF: 0.000537 AC: 78AN: 145370Hom.: 1 Cov.: 22 AF XY: 0.000464 AC XY: 33AN XY: 71050 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2101A>G (p.I701V) alteration is located in exon 1 (coding exon 1) of the CTAGE9 gene. This alteration results from a A to G substitution at nucleotide position 2101, causing the isoleucine (I) at amino acid position 701 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at